NASDAQ$ASND
Ascendis Pharma-ADR · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Headline financials
Revenue & EPS history
Ascendis Pharma · Revenue · Quarterly
€1.58M
Q2 2020-55.6%vs Q2 2019
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
+1.5%
Avg return
Earnings day
+2.7%
Avg return
5 days after
+2.7%
Avg return
30 days after
53%
21 / 40 earnings
Positive
+23.0%
Q2 2021
Best reaction
-13.7%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2024 | -2.7% | +2.8% | -2.3% | |
| Q3 2026 | +3.6% | +9.0% | +10.6% | |
| Q4 2025 | +13.0% | +23.8% | +21.3% | |
| Q2 2024 | -13.7% | -13.9% | +1.8% | |
| Q3 2023 | +0.3% | -4.4% | +15.2% | |
| Q2 2023 | +5.8% | -0.7% | -8.4% | |
| Q1 2023 | -8.5% | +12.5% | +17.4% | |
| Q4 2022 | +4.2% | +0.3% | -3.4% | |
| Q3 2022 | +2.6% | +6.9% | +7.4% | |
| Q2 2022 | +12.5% | +15.6% | +8.8% | |
| Q1 2022 | -3.2% | +2.5% | +0.2% | |
| Q4 2021 | -3.0% | -3.0% | +6.6% | |
| Q3 2021 | -2.4% | -3.5% | -11.8% | |
| Q2 2021 | +23.0% | +26.7% | +34.7% | |
| Q1 2021 | +0.5% | -0.2% | +4.9% | |
| Q4 2020 | +3.4% | +1.3% | -13.4% | |
| Q3 2020 | +3.1% | +1.7% | +10.8% | |
| Q2 2020 | -0.2% | +1.0% | -1.8% | |
| Q1 2020 | +3.9% | +4.1% | +3.4% | |
| Q4 2019 | -1.5% | +6.6% | +4.0% | |
| Q3 2019 | +0.8% | +0.7% | +9.1% | |
| Q2 2019 | -1.2% | -0.4% | -14.5% | |
| Q1 2019 | -2.5% | +1.3% | -10.0% | |
| Q4 2018 | +3.7% | +1.4% | +6.7% | |
| Q3 2018 | +14.4% | +15.9% | +2.8% | |
| Q2 2018 | -6.3% | -5.9% | -6.1% | |
| Q1 2018 | -2.6% | -4.1% | -10.0% | |
| Q4 2017 | +3.5% | -4.9% | +0.2% | |
| Q3 2017 | +5.5% | +4.2% | +5.1% | |
| Q2 2017 | -2.6% | -1.3% | +5.5% | |
| Q1 2017 | -2.7% | -7.0% | -11.6% | |
| Q4 2016 | +1.5% | -4.6% | -2.5% | |
| Q3 2016 | -0.2% | -0.2% | -1.3% | |
| Q2 2016 | +8.5% | +7.2% | +11.0% | |
| Q1 2016 | -0.3% | — | — | |
| Q4 2015 | -3.5% | — | — | |
| Q3 2015 | -3.4% | — | — | |
| Q2 2015 | +7.6% | — | — | |
| Q1 2015 | +2.7% | — | — | |
| Q4 2014 | -2.2% | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro